Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Hmmm, good news, and bashers get more desperate. Or is it really simply "basher," not plural?
More red? Not shorting, are you?
LOL. There's more to this agreement than customer-vendor, (people buying HP ink to print whatever they want, per your example.) Read the text. This is a _sales_and_marketing_ agreement. Beckman Coulter wouldn't market something they thought was trash, now would they?
Just posted this in the Beckman Coulter stock forum, on Google Finance. Maybe some folks over there will be interested in this deal, between these two companies.
http://finance.google.com/group/google.finance.4195/browse_thread/thread/8f7bdd6124cdd5f7/2b8adcaa09a5b14c#2b8adcaa09a5b14c
DNAPrint Genomics and Beckman Coulter Sign Sales and Marketing Agreement
From: xtrop...@gmail.com
Date: Thurs, Nov 15 2007 12:45 pm
DNAPrint(R) Genomics and Beckman Coulter Sign Sales and Marketing Agreement for DNAWitness(TM) and AncestryByDNA(TM)
Thursday November 15, 7:30 am ET
http://biz.yahoo.com/iw/071115/0328816.html
This is great news, especially for DNAPrint Genomics, clearly the beaten-down "little guy" in this deal.
It's not often that you see a big company like Beckman Coulter (stock price $69.30, market cap $4.35 billion,)entering a deal with a company whose stock is trading at less than a penny (and market cap of only 3.28 million, currently.) I'm hoping DNAPrint's financial difficulties will soon be behind them. I hate to see a great company with great products be ground into the mud, as it has been.
Go, DNAPrint! My favorite penny stock, by a long shot.
Disclosure: I own a full position in DNAG. Just topped it off today.
This deal with Beckman Coulter is outstanding, one more encouraging development!
My share count is now: 1,615,900
(I'd buy a lot more, but I don't want to unbalance my portfolio. I have a full position in DNAG, any more and my investment banker would start questioning my sanity. LOL.)
Well, someone obviously wishes so.
> NEW lows coming soon after this nightmare of a read.
Liz, I'm in complete agreement. I'm still in buy mode with DNAG. It's the best time ever to buy, in my opinion. Too bad the credit market is so tight now, but DNAG already has promising revenue streams (I'm especially encouraged by the DNA Direct partnership, which apparently brings DNAG's ancestry testing squarely into the mainstream,) a great product pipeline, and the credit squeeze won't last forever. If their revenue streams grow quickly enough, they may not even need any new financing, though that route would likely slow some things down.
If there's "scamming" involved, would the DNAG insiders own so much stock? No, of course not. They had plenty of opportunities to sell, but didn't. Gives you pause for thought?
Stockboy, you must be the only person shorting DNAG, LOL. Or you want to trick people into selling their shares ever-cheaper to you. Can't you read between the lines? Dutchess has not exercised those because it estimates it has more to gain by allowing DNAG to continue operating, and pay its debt back in good time. Credit market is very tight now, meaning it pays to wait for that reason alone. Also, you seem to be conveniently discounting DNAG's emerging revenue streams, and product pipeline. Why all negative, all the time? Does a dead horse require vigilant beatings?
True, that is an extremely low level of short interest.
Not really on topic, but I thought I should clear this up:
http://en.wikipedia.org/wiki/Google
The name "Google" originated from a misspelling of "googol", which refers to 10^100 (the number represented by a 1 followed by one-hundred zeros). Having found its way increasingly into everyday language, the verb "google", was added to the Merriam Webster Collegiate Dictionary and the Oxford English Dictionary in 2006, meaning "to use the Google search engine to obtain information on the Internet."
> The boys at Google are still most likely looking for porn
> sights on the web(That is where the name 'google' came
> from!!) Hopefully they see DNAG on the radar scope also!!
Great time to buy more, with limit orders, then.
Bashers sure are vigilant/persistent... why so much attention? Does a dead horse attract throngs of people who beat it? No, but a promising penny stock does! People wanting to profit from it in one way or another... easy to deceive most of the people, most of the time, I suppose. But that's the "dark side" and I choose to not go there.
FYI - More DNAG stock visibility, please don't do the knee-jerk shuffle. (See my previous message in thread.) Let's let this stock build up a support base like it deserves. No more pump-and-dump disappointment for everyone (but the pump-and-dump chronic exploiters.) DNAG deserves to build up support and fly. Aside from increased visibility and good advice, we are all obviously waiting on news, especially funding news.
Yep, it sure is!
By the way, a few more people may be looking at DNAG stock, as I posted a message mentioning it here, in a discussion forum of Google stock (someone asked about penny stocks, and I answered) :
http://finance.google.com/group/google.finance.694653/browse_thread/thread/7801c5ba91d76f69/e68ac104d4148ffb#e68ac104d4148ffb
Now don't everyone do the knee-jerk "DNAG shuffle" when someone (or some people) decides to buy in and the price starts going up. We're waiting on news. But if enough new people decide to buy in, we could start seeing a solid support base for higher prices.
.5 cents per share is the low. .005 cents per share, DNAG has never approached that. .005 dollars per share = .5 cents per share.
> would you mind asking your investment banker what the difference is between .5 cents per share as compared to .005 cents per share?
For what it's worth, my investment banker isn't concerned with the stock price, he thinks it's holding up well, all things considered. I agree. He bought in with me at around .7 cents per share. Going down to .5 cents per share is nothing to be concerned about. When news comes, particularly financing news and/or revenue news, everything changes, and the .5 cents will be nothing more than trivia.
Obtaining new funding, on the best terms possible, takes significant time. Especially when the credit markets are so tight, as they are now, and when DNAG is so sensitized to funding terms (after Dutchess.)
If DNAG hasn't obtained all the funding they're looking for, yet, I'm sure they are working on it. Just give them some time. Meanwhile, who cares how low the stock goes? Is anyone really planning on selling now, before funding news and the intended buybacks come? I can only speak for myself, but there's no way I'd sell now. Actually, if the stock price drops further, that just makes it an even better buy, for anyone still looking to average down their price per share and increase their holdings, and also makes it easier for the company to execute meaningful buybacks (in the sense of reducing outstanding shares.) Just my two cents.
What are you talking about, stockboy? "New lows" would indicate actual "new lows," not merely matching a previous low, which is what we saw today. Try again next time? Better brush up, your scaremongering is falling flat.
P.S., one researcher who appears to have a reasonably good grasp of these things, is Philip Deitiker. He's the owner of this Yahoo group:
http://tech.groups.yahoo.com/group/DNAanthro/
And he participates in this Yahoo group:
http://tech.groups.yahoo.com/group/Paleoanthro/
...in case anyone was interested. There are many posts (messages) in both of those groups, that shed light on such questions and problems.
Here's an example of just how messy and uncertain genetic inheritance analysis can be... In SE Asia, there are genes that turn up, that also turn up in Africa. "Out of Africa" proponents, of course, (of which I am not one,) assume those genetic elements stem from migrations out of Africa. But here's the problem... along all known and putative migration routes, there is a disjunction - those genes are not found along the routes, only in Africa and in SE Asia. I won't get into great detail here, but there are physical anthropologists who think a likely explanation is multiregional evolution, involving established regional populations that predate the "Out of Africa (2)" postulated event. Anyway, to put this into simple terms that apply to ancestry testing, the same or similar genetic elements could indicate African or SE Asian ancestry. And what happened to the population(s) (ancestral or otherwise) that connect those two population pockets? There is a lot of uncertainty. DNAPrint does a very competent job, in my opinion, in making sense of the data in an informative but not over-reaching way.
Frog, you seem to be misled. Getting a lot of samples from the currently existing populations is very easy, and populations can even be multiplied arbitrarily! The long lists of samples on that website *do not* correlate 1:1 with the reliable results; it's just not possible, even if people never migrated.
Correlating genetic material accurately to ancestral populations is quite different. Pinpointing the exact place a living person lives, or was born, is of course usually possible. But with population genetics, it's usually not possible. What is achievable is constrained by statistics and the nature of genetic inheritance, which include factors such as genetic drift, horizontal gene transfer (usually driven by selection of some kind, either of the genetic element in question or something linked to it,) loss of genes, etc. It's a messy statistical proposition, and DNAPrint is better at it than anyone else, in my opinion.
Yes, my investment banker, in particular, bought DNAG stock. He's been in the business for more than 20 years.
> DNAG goes much further than just the four
Exactly.
In other words, with high risk and potential high gain investments, "if at first you don't succeed, try, try, again." Or as my investment banker said, "You have to keep doing it." Many people get stung once or twice and quit. Not the way to play penny stocks. Even worse if they put too much into one stock.
With bankruptcy, there could be a buyout, or a liquidation of assets. In the worst of the worst scenarios, creditors might get everything, and stockholders not be left with anything to be dispersed. In that case, contingency planning is, not putting all your eggs in one basket. (Smart investing, including diversification.) With higher risk investments, obviously including "penny stocks," this is even more important, than with lower risk investments. But the gain can be much higher, as well. Picking the right penny stocks to back, and shrewdly investing in them, can yield a lot. I know some investment banking veterans that have made millions that way. No reason we can't, either. Just don't bet all your $ on one horse.
I think a buyout is a sort of a "worst case scenario," but there's a strong possibility that prepared shareholders would benefit from even that. Of course, improvement in the financing and revenue areas, without a buyout, is much more desired! Contingency planning - every investor's best friend.
Also note, DNAPrint is the only one listed as doing their own in-house testing. That is a very important factor, for stockholders. Otherwise, money is flowing out of the company for the testing, rather than into it.
http://www.isogg.org/eochart.htm
OK, EthnoAncestry says a "Total genomic ancestry test" is "coming soon." "Coming soon" does not make them a current competitor.
Link: http://www.ethnoancestry.com/products.htm
DNATribes reportedly has some autosomal testing available now. http://www.dnatribes.com/faq.html
They were reportedly founded in 2006.
http://www.isogg.org/eochart.htm
Note, in addition to DNA Direct, both GeneTree, and Trace Genetics, use DNAPrint's testing (reflected in the chart, showing lab used as "AncestryByDNA.") DNAPrint appears to be the clear leader.
Also note, DNA Direct chose to offer DNAPrint's ancestry testing, not either of those others that Frog mentioned. There must be some reason(s) behind their choice.
On further examining their websites, they make vague mentions of testing beyond mtDNA and yDNA. It doesn't appear, in my opinion, to approach what DNAPrint does, though. A lot more information should be available, from those companies, if they want to be considered serious competitors.
Stockhlder101,
You're right, a buyout could be very lucrative, at least for those shareholders with foresight enough to pick up a bunch of cheap shares, to average their price per share down. Some people, however, will never learn, and that shouldn't suprise anyone. I think some people have issues, including martyr complexes, and those psychological dramas just don't interest me. I'm poised to make $ even if I get .8 cents per share, in the next year or two. But I'm holding out for the possibility of much greater gains. It's a calculated risk, and I don't put all my eggs in one basket. Some eggs may go rotten, but that one egg that doesn't, could bring me a whole lot of $. Plus, I like to think I'm helping to support a good cause - DNAPrint is already helping the world in some ways (including cutting edge work supporting law enforcement, and the best ancestry tests in the world,) and could help in many other ways, further down the line, if not derailed. Stay on the rails, DNAPrint, we're cheering for you! Please, pay no attention to those negative folks who will never learn. Always focus on, and act on, the positive!
Sorry for rambling, but I thought it relevant.
We're waiting on funding news, obviously. Gratuitous doom and gloom forecasting, is that relevant? Does that work well for you at social gatherings, too? I think we all know DNAG's funding developments are of crucial importance right now, but luckily, they do have revenue streams, as well. (Including the DNA Direct agreement.) So even if it takes them some time to shop around and finally get the funding they want, they should be able to hang in there for some time. Having revenue helps immensely, as my broker agrees; operations can be scaled back until the funding is secured. Are you saying that people will stop buying DNAPrint products? Or that they will never get more funding? I think both of those scenarios are very unlikely; sales will increase, and funding will come. It doesn't pay to jump the gun and accept the first funding offer, particularly in today's tight credit market. DNAPrint learned their lesson, they want better funding than they had before, not worse. So, I'm prepared to give them time to do so - more power to them! While eagerly awaiting funding news. I'm extremely happy to be a DNAG shareholder.
Thanks, you too!
StatStats, good points.
Oh please. It's clear that DNAPrint Genomics will be paid to run those tests. Why else would such an agreement exist?
Bashers aren't bothered by the facts, they're like True Believers. Maybe we should put them on "ignore," but then newbies might still be swayed by their chronic kvetching.
Some posting behaviors may seem confusing at times, especially for newbies. Perhaps this will help shed some light on some of the goings-on:
The Method of Operation of the Professional Basher
http://www.willywizard.com/method_of_operation_of_the_profe.htm
Typo; currently at .0060
Your scaremongering is in fine form today. Bravo?
"New lows" have not been reached. A single person sold today at .0055, and it bounced up right after that, currently at .0066. If we aren't at rock bottom, I don't know what is. Financing news, and we can fly.